GENE ONLINE|News &
Opinion
Blog

Pavel Ryzhov

WRITTEN BY Pavel Ryzhov

GSK, Vir Collaboration Drives Advanced Clinical Trial for Novel COVID-19 Antibody Forward
2020-10-11
BARDA Funds Development of Live Biotherapeutic Product Against C. difficile Infections
2020-10-05
EU Commission Grants Marketing Authorization for Gilead’s Rheumatoid Arthritis Treatment
2020-10-04
Amgen’s KRAS Inhibitor Registers Long-Lasting Performance in Solid Tumors
2020-09-27
Roche Invests €380 Million on Inflammatory Disease Focusing Irish Biotech
2020-09-24
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
3SBio Partnering with Samsung Bioepis Co-developing Bevacizumab Biosimilar for NSCLC
2020-09-16
AI Drug Pioneer Recursion Pharma Raises $239 Million Led by Leaps By Bayer
2020-09-12
A German Biotech Company Developing Novel Precision Canonical Antibodies was Founded and Funded
2020-09-10
Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
2020-09-06
Bristol-Myers-Squibb Anticipates FDA Approval for CC-486 as a Treatment for Acute Myeloid Leukemia
2020-08-30
USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy
2020-08-26
OneOncology Enters First-of-its-Kind Partnership with FMI to Advance Personalized Medicine at Community Oncology Practices
2020-08-18
COVID-19 Vaccine: Russia Announces Approval of “Sputnik V” Despite Concerns Over Safety
2020-08-12
FDA Greenlights Roche’s Epstein-Barr Virus Test to Augment Transplant Patient Care
2020-08-07
1 2 3
Scroll to Top